# TICAGRELOR
> **ANDA218962** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2025-10-28
## Drug
- **FDA Application Number:** ANDA218962
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TICAGRELOR
- **Generic name:** TICAGRELOR
- **Active ingredients:** TICAGRELOR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Radha Pharmaceuticals INC
- **First approval:** 2025-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218962)
---
*MORVS · CC0 1.0*